Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing
Plus news about Breye, Immix and Aptadir. Ascletis takes on injectables with psoriasis pill: The Hong Kong-listed biotech is developing a small-molecule IL-17A inhibitor, going after the same target as injectables ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.